The ideal stent to treat very calcified lesions needs (1) a high radial force to resist the elastic recoil and radial crush and (2) a moderate outward expansive force to provide sufficient vessel ...
Please provide your email address to receive an email when new articles are posted on . You've successfully added to your alerts. You will receive an email when new content is published. Click Here to ...
A drug-eluting stent, or DES, is a small, metal mesh tube placed in a blocked coronary artery. The metal is coated in medicine and helps reopen your artery and keep it open. Stents are used to treat ...
Feb. 20 (UPI) --Researchers at Washington University in St. Louis have found same-day procedures to treat narrowing of the arteries in the heart using the arm can save millions of dollars. The study ...
On the day before your treatment, you may be asked to withhold some of your blood pressure medication. This is so it does not interfere with the blood pressure response during the actual stent ...
ABBOTT PARK, Ill., Abbott today announced it received approval from the U.S. Food and Drug Administration (FDA) for XIENCE SierraTM, the newest generation of the company's gold-standard XIENCE ...
WASHINGTON -- The Neuroguard carotid stent system, with its integrated embolic filter, continued to show good results at 2 years for people with carotid artery stenosis deemed poor candidates for ...
This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated. HINSDALE, Ill. — Smaller, sleeker, faster.
Health and Me on MSN
Can heart stents decline over time and need replacement? Cardiologist explains
Can heart stents decline over time or need replacement? A cardiologist explains how stents work, why problems can develop, ...
Carotid stent surgery is one of two procedures that can be used to treat carotid artery stenosis. This procedure is considered a less invasive option with a faster recovery time. However, it does have ...
NATICK, Mass., Boston Scientific Corporation today announced that it has completed enrollment in the ORION clinical trial, which is designed to evaluate the Company's EPIC™ Self-Expanding Nitinol ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results